Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@anexpertone Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1951734368944480256.png) @anexpertone AnExpertOne

AnExpertOne posts on X about $pgen, approved, money, upside the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::1951734368944480256/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1951734368944480256/c:line/m:interactions.svg)

- X Week XXXXX +15%
- X Month XXXXXX -XX%

### Mentions: X [#](/creator/twitter::1951734368944480256/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1951734368944480256/c:line/m:posts_active.svg)

- X Week XX -XX%
- X Month XX -XXXX%

### Followers: XX [#](/creator/twitter::1951734368944480256/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1951734368944480256/c:line/m:followers.svg)

- X Week XX +16%
- X Month XX +45%

### CreatorRank: undefined [#](/creator/twitter::1951734368944480256/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1951734368944480256/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1951734368944480256/influence)
---

**Social category influence**
[finance](/list/finance)  XX%

**Social topic influence**
[$pgen](/topic/$pgen) #10, [approved](/topic/approved) 20%, [money](/topic/money) 5%, [upside](/topic/upside) 5%, [$qure](/topic/$qure) 5%, [faster](/topic/faster) 5%, [long term](/topic/long-term) 5%, [good news](/topic/good-news) 5%, [mega](/topic/mega) 5%, [brains](/topic/brains) X%

**Top accounts mentioned or mentioned by**
[@steptradez](/creator/undefined) [@investrch](/creator/undefined) [@shortsellerst](/creator/undefined) [@amaymd](/creator/undefined) [@geneinvesting](/creator/undefined) [@invest_rch](/creator/undefined)

**Top assets mentioned**
[uniQure N.V. (QURE)](/topic/$qure) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla)
### Top Social Posts [#](/creator/twitter::1951734368944480256/posts)
---
Top posts by engagements in the last XX hours

"Surprised that they are still fighting $PGEN here down XX% in a month and RSI only at XX. But I sure would love to pick up some shares at $X or even $XXXX. New & approved FDA Tx is available & looks quite easy to Order & have delivered quite fast. They either have quick uptake w/ many patients treated soon or some very good guidance going forward(by NOV). A Deal signed would be nice if they can get it done &/or some new data"  
[X Link](https://x.com/anexpertone/status/1973039142649962937) [@anexpertone](/creator/x/anexpertone) 2025-09-30T14:56Z XX followers, XXX engagements


"Used to know what some of those Kirk companies were but think many of them are for various trusts family members Third Sec. etc. - maybe wanted to give some money to family & friends. Odd not sold any over $X but possibly had to wait for an open window time to sale $PGEN"  
[X Link](https://x.com/anexpertone/status/1973400401958367620) [@anexpertone](/creator/x/anexpertone) 2025-10-01T14:51Z XX followers, XXX engagements


"$PGEN Precigen Home Page Site is more informative than ever to include this one (Link/glowing news story) from the RRP Foundation FIRST EVER ************************** Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP) Papzimeos the first-ever treatment approved for RRP is a moment for celebration and reflection FORT WORTH Texas--(BUSINESS WIRE)--The Recurrent Respiratory Papillomatosis Foundation (RRPF) is excited to share the news that the U.S. Food and Drug Administration (FDA) has granted full approval to Precigens Papzimeos (zopapogene"  
[X Link](https://x.com/anexpertone/status/1973752656779768172) [@anexpertone](/creator/x/anexpertone) 2025-10-02T14:11Z XX followers, XXX engagements


"$PGEN One more - & wow Precigen (chart) RSI level now at XX closing in on the 30s - unseen levels since May How in the hell does that make any sense Shorts back w/ a vengence working to convince us that nothing else good is coming Gee maybe bankruptcy.lol. No worries though - I am not at a full position - maybe too many upside calls though.ha"  
[X Link](https://x.com/anexpertone/status/1973756540092907986) [@anexpertone](/creator/x/anexpertone) 2025-10-02T14:26Z XX followers, XXX engagements


"Idiotic moron still working it. $PGEN *** RSI @ XX ***- lowest level since way back in April. 🤡 First to Market Best RRP Therapy to Date = Worthless per current price.stupid market atm"  
[X Link](https://x.com/anexpertone/status/1976664664567370099) [@anexpertone](/creator/x/anexpertone) 2025-10-10T15:02Z XX followers, XXX engagements


"$PGEN Maybe not as exciting as $QURE w/ great data on Huntingtons' that they can charge a Million or more but w/ Precigen at less than 1/4 the valuation of QURE and a more appealing *price point & patients (likely) lining up fast they should do well in the market faster.imo. A long term Decent PIPE too (more to come). Oh wait QURE not even approved yet for HD right"  
[X Link](https://x.com/anexpertone/status/1977742509343121507) [@anexpertone](/creator/x/anexpertone) 2025-10-13T14:25Z XX followers, XXX engagements


"MM's eating up them Calls expiring this OE Week but of course Maybe we get 'more' good news via $PGEN this week (like what occured in August) if only.ha. 1) News that the Tx Launch is going well. 2) Some Pharma views Precigen as too cheap - wants a piece of the Pie or the Whole - would be nice but oh I know likely not so soon"  
[X Link](https://x.com/anexpertone/status/1977773917851836704) [@anexpertone](/creator/x/anexpertone) 2025-10-13T16:30Z XX followers, XXX engagements


"Precigen looking unusually Strong this (OE) Week thus far. Was it the hit down ahead of OE to now be the start of the run-up into Earnings Call week in NOV with some possible very good news Sure hit a mega low price from where the high was. $PGEN"  
[X Link](https://x.com/anexpertone/status/1978103153833709692) [@anexpertone](/creator/x/anexpertone) 2025-10-14T14:18Z XX followers, XXX engagements


"Very nice Did I call it (similar) or what.ha. $PGEN"  
[X Link](https://x.com/anexpertone/status/1977728722967941308) [@anexpertone](/creator/x/anexpertone) 2025-10-13T13:30Z XX followers, XXX engagements


"$PGEN Great DATA - yet peon brain(s) took back over. From Precigen Key data highlights from the AAO-HNSF presentation: XX out of the XX complete responders (83%) in the pivotal study demonstrated ongoing complete responses as of the September XX 2025 data cutoff with: Median duration of follow-up of XX months (range: 27-37 months); Median duration of complete response yet to be reached; and No new safety events observed during long-term follow-up. Prolonged reduction in the requirement for surgical intervention to manage RRP was observed throughout long-term follow-up of evaluable study"  
[X Link](https://x.com/anexpertone/status/1977741164301230553) [@anexpertone](/creator/x/anexpertone) 2025-10-13T14:20Z XX followers, XXX engagements


"Other than it being OE week why the dummy-dump down Only seeing some dumping of OCT calls/Puts expiring on Friday this week. They likely pivot & buy more NOV calls soon I bet $NTLA"  
[X Link](https://x.com/anexpertone/status/1977792220993646698) [@anexpertone](/creator/x/anexpertone) 2025-10-13T17:43Z XX followers, XXX engagements


"Very good on $PGEN The FDA approved Papzimeos early with a broader label than expected. When we did the deal in Dec the stock was around $XXXX. It ended July at $XXXX and surged to over $X after approval. Its since pulled back to a low of $XXXX on par with historical post-approval pullbacks. In September the company raised a $125M credit facility which gives them time to commercialize Papzimeous a process thats fraught with risk and delays. Since the papillomatosis patient population is in dire need with no other treatment options theres a high incentive for providers and payers to work"  
[X Link](https://x.com/anexpertone/status/1978444129764880403) [@anexpertone](/creator/x/anexpertone) 2025-10-15T12:53Z XX followers, XXX engagements


"$PGEN Nice strong close near HOD - think I sold a few calls to a Huge buyer of"  
[X Link](https://x.com/anexpertone/status/1979301735853363225) [@anexpertone](/creator/x/anexpertone) 2025-10-17T21:41Z XX followers, XXX engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@anexpertone Avatar @anexpertone AnExpertOne

AnExpertOne posts on X about $pgen, approved, money, upside the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXXXX +15%
  • X Month XXXXXX -XX%

Mentions: X #

Mentions Line Chart

  • X Week XX -XX%
  • X Month XX -XXXX%

Followers: XX #

Followers Line Chart

  • X Week XX +16%
  • X Month XX +45%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence finance XX%

Social topic influence $pgen #10, approved 20%, money 5%, upside 5%, $qure 5%, faster 5%, long term 5%, good news 5%, mega 5%, brains X%

Top accounts mentioned or mentioned by @steptradez @investrch @shortsellerst @amaymd @geneinvesting @invest_rch

Top assets mentioned uniQure N.V. (QURE) Intellia Therapeutics, Inc (NTLA)

Top Social Posts #


Top posts by engagements in the last XX hours

"Surprised that they are still fighting $PGEN here down XX% in a month and RSI only at XX. But I sure would love to pick up some shares at $X or even $XXXX. New & approved FDA Tx is available & looks quite easy to Order & have delivered quite fast. They either have quick uptake w/ many patients treated soon or some very good guidance going forward(by NOV). A Deal signed would be nice if they can get it done &/or some new data"
X Link @anexpertone 2025-09-30T14:56Z XX followers, XXX engagements

"Used to know what some of those Kirk companies were but think many of them are for various trusts family members Third Sec. etc. - maybe wanted to give some money to family & friends. Odd not sold any over $X but possibly had to wait for an open window time to sale $PGEN"
X Link @anexpertone 2025-10-01T14:51Z XX followers, XXX engagements

"$PGEN Precigen Home Page Site is more informative than ever to include this one (Link/glowing news story) from the RRP Foundation FIRST EVER ************************** Hope Realized: FDA Approves Papzimeos for Adults with Recurrent Respiratory Papillomatosis (RRP) Papzimeos the first-ever treatment approved for RRP is a moment for celebration and reflection FORT WORTH Texas--(BUSINESS WIRE)--The Recurrent Respiratory Papillomatosis Foundation (RRPF) is excited to share the news that the U.S. Food and Drug Administration (FDA) has granted full approval to Precigens Papzimeos (zopapogene"
X Link @anexpertone 2025-10-02T14:11Z XX followers, XXX engagements

"$PGEN One more - & wow Precigen (chart) RSI level now at XX closing in on the 30s - unseen levels since May How in the hell does that make any sense Shorts back w/ a vengence working to convince us that nothing else good is coming Gee maybe bankruptcy.lol. No worries though - I am not at a full position - maybe too many upside calls though.ha"
X Link @anexpertone 2025-10-02T14:26Z XX followers, XXX engagements

"Idiotic moron still working it. $PGEN *** RSI @ XX ***- lowest level since way back in April. 🤡 First to Market Best RRP Therapy to Date = Worthless per current price.stupid market atm"
X Link @anexpertone 2025-10-10T15:02Z XX followers, XXX engagements

"$PGEN Maybe not as exciting as $QURE w/ great data on Huntingtons' that they can charge a Million or more but w/ Precigen at less than 1/4 the valuation of QURE and a more appealing *price point & patients (likely) lining up fast they should do well in the market faster.imo. A long term Decent PIPE too (more to come). Oh wait QURE not even approved yet for HD right"
X Link @anexpertone 2025-10-13T14:25Z XX followers, XXX engagements

"MM's eating up them Calls expiring this OE Week but of course Maybe we get 'more' good news via $PGEN this week (like what occured in August) if only.ha. 1) News that the Tx Launch is going well. 2) Some Pharma views Precigen as too cheap - wants a piece of the Pie or the Whole - would be nice but oh I know likely not so soon"
X Link @anexpertone 2025-10-13T16:30Z XX followers, XXX engagements

"Precigen looking unusually Strong this (OE) Week thus far. Was it the hit down ahead of OE to now be the start of the run-up into Earnings Call week in NOV with some possible very good news Sure hit a mega low price from where the high was. $PGEN"
X Link @anexpertone 2025-10-14T14:18Z XX followers, XXX engagements

"Very nice Did I call it (similar) or what.ha. $PGEN"
X Link @anexpertone 2025-10-13T13:30Z XX followers, XXX engagements

"$PGEN Great DATA - yet peon brain(s) took back over. From Precigen Key data highlights from the AAO-HNSF presentation: XX out of the XX complete responders (83%) in the pivotal study demonstrated ongoing complete responses as of the September XX 2025 data cutoff with: Median duration of follow-up of XX months (range: 27-37 months); Median duration of complete response yet to be reached; and No new safety events observed during long-term follow-up. Prolonged reduction in the requirement for surgical intervention to manage RRP was observed throughout long-term follow-up of evaluable study"
X Link @anexpertone 2025-10-13T14:20Z XX followers, XXX engagements

"Other than it being OE week why the dummy-dump down Only seeing some dumping of OCT calls/Puts expiring on Friday this week. They likely pivot & buy more NOV calls soon I bet $NTLA"
X Link @anexpertone 2025-10-13T17:43Z XX followers, XXX engagements

"Very good on $PGEN The FDA approved Papzimeos early with a broader label than expected. When we did the deal in Dec the stock was around $XXXX. It ended July at $XXXX and surged to over $X after approval. Its since pulled back to a low of $XXXX on par with historical post-approval pullbacks. In September the company raised a $125M credit facility which gives them time to commercialize Papzimeous a process thats fraught with risk and delays. Since the papillomatosis patient population is in dire need with no other treatment options theres a high incentive for providers and payers to work"
X Link @anexpertone 2025-10-15T12:53Z XX followers, XXX engagements

"$PGEN Nice strong close near HOD - think I sold a few calls to a Huge buyer of"
X Link @anexpertone 2025-10-17T21:41Z XX followers, XXX engagements

@anexpertone
/creator/twitter::anexpertone